Related Experiment Video

Updated: Jul 24, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Amoxicillin-clavulanate potassium compared with cefaclor for acute otitis media in infants and children

P H Kaleida, C D Bluestone, H E Rockette

    The Pediatric Infectious Disease Journal
    |March 1, 1987
    PubMed

    Insights

    Amoxicillin-clavulanate potassium and cefaclor showed similar efficacy in treating acute otitis media (OM) in children. While amoxicillin-clavulanate potassium had more gastrointestinal side effects, both treatments resulted in comparable recurrence rates for middle ear disease.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Pharmacology

    Background:

    • Acute otitis media (OM) is a common childhood infection.
    • Beta-lactamase-producing bacteria can complicate OM treatment.
    • Evaluating antibiotic efficacy and recurrence is crucial for pediatric care.

    Purpose of the Study:

    • To compare the efficacy of amoxicillin-clavulanate potassium versus cefaclor in treating acute otitis media in infants and children.
    • To assess recurrence rates and adverse effects associated with each antibiotic.

    Main Methods:

    • A randomized trial involving 133 infants and children with documented acute otitis media.
    • Participants received either oral amoxicillin-clavulanate potassium or cefaclor.
    • Follow-up assessments occurred at multiple time points and upon recurrence of symptoms.

    Main Results:

    • Both amoxicillin-clavulanate potassium and cefaclor demonstrated high initial resolution rates for otalgia/otorrhea.
    • No significant differences were observed in the resolution of otitis media with effusion between the two groups.
    • Recurrence rates of acute OM/otorrhea were similar, with approximately 50% recurrence in subjects with or without middle ear effusion at 10 days.
    • Amoxicillin-clavulanate potassium was associated with a significantly higher incidence of mild, primarily gastrointestinal, adverse effects.

    Conclusions:

    • Amoxicillin-clavulanate potassium and cefaclor are comparable in treating acute otitis media in children.
    • Parents and clinicians should be aware of the higher likelihood of gastrointestinal side effects with amoxicillin-clavulanate potassium.
    • Middle ear effusion status at 10 days did not predict recurrence rates, suggesting a need for continued monitoring post-treatment.

    More Related Videos

    Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

    Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

    Published on: January 22, 2021

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

    Published on: July 24, 2021

    Related Concept Videos

    Acute Pharyngitis01:30

    Acute Pharyngitis

    Introduction
    Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
    Classification
    Acute pharyngitis can be categorized based on its underlying cause:
    Tonsillitis II: Management01:26

    Tonsillitis II: Management

    This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

    Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...